Clairo

Cardiac Specialist I

Costa Rica

Auto‑apply with AI Apply

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

Clinical Trials, Medical Devices, HealthcareIndustries

Requirements

Candidates should possess an Associate’s Degree (preferred Bachelor’s Degree or related degree) or equivalent combination of education and experience, an ECG certificate, and demonstrated knowledge of cardiovascular physiology and anatomy. They must have 1-2 years of experience in ECG Core Lab or working under GCP, GDPR, and data privacy regulations, along with experience working in a team environment and a collaborative work ethic. Strong computer competencies, including Google, Microsoft suite (including Excel), and database management, are also required.

Responsibilities

The Cardiac Specialist I will perform interval duration and rate measurements on digital or paper ECGs according to established Standard Operating Procedures (SOPs), evaluate and place calipers on digital ECGs, utilize validated software to convert PNG images to XML files, assess waveforms for conversion accuracy, accurately calibrate scaling of PDF images, process cardiac data from continuous Holter recordings, extract time-point specific 12-Lead ECG extractions, export XMLs to the designated database, evaluate ECGs for safety/alert findings and provide notification, participate in the Quality Assurance program, and meet or exceed departmental productivity and quality metrics.

Skills

ECG analysis

Cardiovascular physiology

ECG software

ECG calibration

Holter recordings

12-Lead ECG

XML data handling

Data privacy regulations

GCP

GDPR

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

Key Metrics

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free